Robin Fredric Anders

Robin Fredric Anders's AcademicInfluence.com Rankings

Business

#828

World Rank

#910

Historical Rank

Management

#317

World Rank

#342

Historical Rank

business Degrees

Download Badge

Business

Why Is Robin Fredric Anders Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robin Fredric Anders's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. (2002) (503)
Specificity of the Protective Antibody Response to Apical Membrane Antigen 1 (2001) (349)
A Role for Apical Membrane Antigen 1 during Invasion of Hepatocytes by Plasmodium falciparum Sporozoites* (2004) (336)
Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species (2000) (336)
Integral membrane protein located in the apical complex of Plasmodium falciparum (1989) (277)
The Disulfide Bond Structure of Plasmodium Apical Membrane Antigen-1* (1996) (266)
Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness (2009) (261)
Identification of two integral membrane proteins of Plasmodium falciparum. (1988) (255)
Repetitive proteins and genes of malaria. (1987) (253)
Human Antibodies Fix Complement to Inhibit Plasmodium falciparum Invasion of Erythrocytes and Are Associated with Protection against Malaria (2015) (250)
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. (1998) (244)
Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. (1998) (243)
Multiple cross‐reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria (1986) (234)
Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes (1996) (233)
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria (2014) (208)
Structural diversity in the Plasmodium falciparum merozoite surface antigen 2. (1991) (207)
Immune sera recognize on erythrocytes a Plasmodium falciparum antigen composed of repeated amino acid sequences (1984) (202)
Interaction of the Molecular Chaperone αB-Crystallin with α-Synuclein: Effects on Amyloid Fibril Formation and Chaperone Activity (2004) (199)
Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum. (1990) (198)
Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. (2005) (194)
Size variation in chromosomes from independent cultured isolates of Plasmodium falciparum (1985) (184)
Allelic polymorphisms in apical membrane antigen‐1 are responsible for evasion of antibody‐mediated inhibition in Plasmodium falciparum (2004) (182)
Structure of the RESA gene of Plasmodium falciparum. (1986) (177)
Expression of Plasmodium falciparum blood-stage antigens in Escherichia coli: detection with antibodies from immune humans. (1983) (173)
Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum (1986) (168)
Isolate-specific S-antigen of Plasmodium falciparum contains a repeated sequence of eleven amino acids (1983) (167)
Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant. (1999) (150)
Reduced risk of clinical malaria in children infected with multiple clones of Plasmodium falciparum in a highly endemic area: a prospective community study. (1997) (142)
Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum. (1992) (140)
Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. (2000) (138)
Geographical Structure of Diversity and Differences between Symptomatic and Asymptomatic Infections for Plasmodium falciparum Vaccine Candidate AMA1 (2003) (134)
Localization of the ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum in merozoites and ring-infected erythrocytes (1985) (134)
A repetitive antigen of Plasmodium falciparum that is homologous to heat shock protein 70 of Drosophila melanogaster. (1986) (133)
The ring-infected erythrocyte surface antigen of Plasmodium falciparum associates with spectrin in the erythrocyte membrane. (1991) (131)
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children. (2003) (131)
The Most Polymorphic Residue on Plasmodium falciparum Apical Membrane Antigen 1 Determines Binding of an Invasion-Inhibitory Antibody (2006) (130)
Plasmodium falciparum ring-infected erythrocyte surface antigen is released from merozoite dense granules after erythrocyte invasion (1991) (128)
Formation of Hydrogen Peroxide by Group N Streptococci and Its Effect on Their Growth and Metabolism (1970) (121)
Lack of Association between Maternal Antibody and Protection of African Infants from Malaria Infection (2000) (119)
Abundance of intrinsically unstructured proteins in P. falciparum and other apicomplexan parasite proteomes. (2006) (117)
Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro (1982) (112)
Molecular variation in a novel polymorphic antigen associated with Plasmodium falciparum merozoites. (1994) (110)
A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant. (2005) (110)
Isolation and Characterization of Amyloid‐Related Serum Protein SAA as a Low Molecular Weight Protein (1975) (108)
Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition. (2007) (107)
Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria (1995) (105)
Plasmodium falciparum: two antigens of similar size are located in different compartments of the rhoptry. (1990) (105)
The mature-parasite-infected erythrocyte surface antigen (MESA) of Plasmodium falciparum associates with the erythrocyte membrane skeletal protein, band 4.1. (1990) (103)
Binding Hot Spot for Invasion Inhibitory Molecules on Plasmodium falciparum Apical Membrane Antigen 1 (2005) (103)
Selection and affinity maturation of IgNAR variable domains targeting Plasmodium falciparum AMA1 (2004) (103)
Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1). (2002) (102)
Analysis of Infection Characteristics and Antiparasite Immune Responses in Resistant Compared with Susceptible Hosts (1982) (102)
Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum. (1996) (102)
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. (1994) (101)
Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea. (2000) (100)
Characterization of an S antigen synthesized by several isolates of Plasmodium falciparum. (1983) (96)
Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3). (1997) (95)
A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720 (2011) (91)
Amyloid-related serum protein SAA from three animal species: comparison with human SAA. (1977) (91)
Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1 (2013) (89)
Allele Specificity of Naturally Acquired Antibody Responses against Plasmodium falciparum Apical Membrane Antigen 1 (2005) (88)
New Insights into Acquisition, Boosting, and Longevity of Immunity to Malaria in Pregnant Women (2012) (87)
Variable antigen associated with the surface of erythrocytes infected with mature stages of Plasmodium falciparum. (1986) (86)
Plasmodium falciparum: identification and localization of a knob protein antigen expressed by a cDNA clone. (1987) (85)
Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides. (2001) (83)
The Plasmodium falciparum protein RESA interacts with the erythrocyte cytoskeleton and modifies erythrocyte thermal stability. (1994) (81)
Structure of the Malaria Antigen AMA1 in Complex with a Growth-Inhibitory Antibody (2007) (81)
Antigens with repeated amino acid sequences from the asexual blood stages of Plasmodium falciparum. (1988) (81)
Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils. (2009) (80)
The ring-infected erythrocyte surface antigen (RESA) polypeptide of Plasmodium falciparum contains two separate blocks of tandem repeats encoding antigenic epitopes that are naturally immunogenic in man. (1984) (79)
Recombinant protein vaccines against the asexual blood-stages of Plasmodium falciparum (2010) (75)
The complete sequence of the gene for the knob‐associated histidine‐rich protein from Plasmodium falciparum. (1987) (74)
Interspersed blocks of repetitive and charged amino acids in a dominant immunogen of Plasmodium falciparum. (1985) (74)
Strain-Specific Humoral Response to a Polymorphic Malaria Vaccine (2004) (73)
Diversity of agglutinating phenotype, cytoadherence, and rosette-forming characteristics of Plasmodium falciparum isolates from Papua New Guinean children. (1994) (72)
Expression of the RESA gene in Plasmodium falciparum isolate FCR3 is prevented by a subtelomeric deletion (1989) (71)
Sequential Processing of Merozoite Surface Proteins during and after Erythrocyte Invasion by Plasmodium falciparum (2013) (70)
Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity. (2004) (69)
ASSOCIATION OF AMYLOIDOSIS WITH ERYTHEMA NODOSUM LEPROSUM REACTIONS AND RECURRENT NEUTROPHIL LEUCOCYTOSIS IN LEPROSY (1975) (68)
MESA is a Plasmodium falciparum phosphoprotein associated with the erythrocyte membrane skeleton. (1988) (66)
A Plasmodium falciparum MSA-2 gene apparently generated by intragenic recombination between the two allelic families. (1991) (65)
A blood stage antigen of Plasmodium falciparum shares determinants with the sporozoite coat protein. (1985) (65)
Variation in the precursor to the major merozoite surface antigens of Plasmodium falciparum. (1988) (64)
Immunization against Taenia taeniaeformis in mice: studies on the characterization of antigens from oncospheres. (1984) (64)
Mapping a conserved conformational epitope from the M protein of group A streptococci. (1996) (63)
Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity (1986) (59)
An examination of differences in serum antibody specificities and hypersensitivity reactions as contributing factors to chronic infection with the intestinal protozoan parasite, Giardia muris, in mice. (1983) (59)
Allelic variants of the Plasmodium falciparum merozoite surface antigen 2 (MSA-2) in a geographically restricted area of Irian Jaya. (1994) (59)
Factors Affecting the Activity of the Lactate Dehydrogenase of Streptococcus cremoris (1972) (59)
The Evolutionary Consequences of Blood-Stage Vaccination on the Rodent Malaria Plasmodium chabaudi (2012) (58)
Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2. (2008) (58)
A component of an antigenic rhoptry complex of Plasmodium falciparum is modified after merozoite invasion. (1988) (57)
Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan. (2009) (56)
High Affinity Antibodies to Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Malaria (2012) (56)
Sequence of a cDNA encoding a small polymorphic histidine- and alanine-rich protein from Plasmodium falciparum. (1985) (56)
A putative Plasmodium falciparum exported serine/threonine protein kinase. (1997) (55)
Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria (1995) (54)
Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults. (1995) (52)
Amyloid-related serum protein SAA in endotoxin-induced amyloidosis of the mink (1976) (51)
Apical membrane antigen of Plasmodium fragile. (1990) (50)
Metabolism of ethylmorphine and aniline in human fetal liver (1972) (50)
CD4+ T Cells Acting Independently of Antibody Contribute to Protective Immunity to Plasmodium chabaudi Infection After Apical Membrane Antigen 1 Immunization1 (2000) (50)
Merozoite surface protein 2 of Plasmodium falciparum: expression, structure, dynamics, and fibril formation of the conserved N-terminal domain. (2007) (50)
Antibody Recognition of Disordered Antigens. (2016) (49)
Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines (2014) (48)
Variable and common antigens of Babesia bovis parasites differing in strain and virulence. (1982) (48)
Phage-displayed Peptides Bind to the Malarial Protein Apical Membrane Antigen-1 and Inhibit the Merozoite Invasion of Host Erythrocytes* (2002) (47)
The ring-infected erythrocyte surface antigen protein of Plasmodium falciparum is phosphorylated upon association with the host cell membrane. (1990) (47)
Small area variation in prevalence of an S-antigen serotype of Plasmodium falciparum in villages of Madang, Papua New Guinea. (1989) (47)
Insights into the Immunological Properties of Intrinsically Disordered Malaria Proteins Using Proteome Scale Predictions (2015) (46)
Affinity purification of human antibodies directed against cloned antigens of Plasmodium falciparum. (1986) (46)
A cDNA clone expressing a rhoptry protein of Plasmodium falciparum. (1987) (46)
Differential effect of immunoglobulin on the in vitro growth of several isolates of Plasmodium falciparum (1983) (46)
Giardiasis in mice: studies on the characteristics of chronic infection in C3h/He mice. (1981) (45)
Hybridoma-derived antibody with immunodiagnostic potential for schistosomiasis japonica. (1981) (45)
Sorting large numbers of clones expressing Plasmodium falciparum antigens in Escherichia coli by differential antibody screening. (1986) (43)
A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design. (1997) (43)
A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami. (1989) (42)
Molecular variation in Plasmodium falciparum: polymorphic antigens of asexual erythrocytic stages. (1993) (41)
EGCG disaggregates amyloid-like fibrils formed by Plasmodium falciparum merozoite surface protein 2. (2011) (41)
Giardiasis in mice: analysis of humoral and cellular immune responses to Giardia muris (1982) (41)
Antibodies to Malaria Peptide Mimics Inhibit Plasmodium falciparum Invasion of Erythrocytes (2004) (41)
Apical membrane antigen 1 as an anti-malarial drug target. (2011) (40)
A second antigenic heat shock protein of Plasmodium falciparum. (1988) (39)
Antibodies to Polymorphic Invasion-Inhibitory and Non-Inhibitory Epitopes of Plasmodium falciparum Apical Membrane Antigen 1 in Human Malaria (2013) (39)
Structure and inter-domain interactions of domain II from the blood-stage malarial protein, apical membrane antigen 1. (2005) (38)
Connective tissue origin of the amyloid-related protein SAA (1976) (38)
An asparagine-rich protein from blood stages of Plasmodium falciparum shares determinants with sporozoites. (1986) (38)
Polymorphic antigens in Plasmodium falciparum (1989) (37)
Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia. (1989) (36)
Random sequence libraries displayed on phage: identification of biologically important molecules. (2002) (36)
Inhibition by flavonoids of amyloid-like fibril formation by Plasmodium falciparum merozoite surface protein 2. (2010) (36)
Structure of a Plasmodium falciparum gene that encodes a glutamic acid-rich protein (GARP). (1988) (36)
Changes in repeat number, sequence, and reading frame in S-antigen genes of Plasmodium falciparum (1987) (35)
Plasmodium falciparum: differentiation of isolates with DNA hybridization using antigen gene probes. (1985) (35)
Characterisation of two novel proteins from the asexual stage of Plasmodium falciparum, H101 and H103. (2005) (34)
A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid‐like fibrils (2007) (34)
Solution structure of a polypeptide containing four heptad repeat units from a merozoite surface antigen of Plasmodium falciparum. (1995) (34)
FcγRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan (2009) (34)
Selection of an adjuvant for vaccination with the malaria antigen, MSA-2. (1997) (34)
Plasmodium falciparum Merozoite Surface Protein 6 Is a Dimorphic Antigen (2004) (33)
Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria (1991) (33)
Correction: Structure of the Malaria Antigen AMA1 in Complex with a Growth-Inhibitory Antibody (2007) (33)
A suite of kinetically superior AEP ligases can cyclise an intrinsically disordered protein (2019) (33)
Antigenic Characterization of an Intrinsically Unstructured Protein, Plasmodium falciparum Merozoite Surface Protein 2 (2012) (33)
Plasmodium falciparum: mapping the membrane-binding domain in the ring-infected erythrocyte surface antigen. (1994) (33)
The Malaria Antigens (1999) (33)
Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance (2017) (33)
Rotational dynamics of the integral membrane protein, band 3, as a probe of the membrane events associated with Plasmodium falciparum infections of human erythrocytes. (1990) (32)
Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia. (1988) (32)
Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum. (1991) (32)
IgG1 hypergammaglobulinaemia in chronic parasitic infections in mice: evidence that the response reflects chronicity of antigen exposure. (1979) (31)
Humoral response to Plasmodium falciparum ring-infected erythrocyte surface antigen in a highly endemic area of Papua New Guinea. (1995) (31)
Putative glycophorin-binding protein is secreted from schizonts of Plasmodium falciparum. (1987) (31)
Molecular karyotyping of the rodent malarias Plasmodium chabaudi, Plasmodium berghei and Plasmodium vinckei. (1989) (31)
Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans). (1988) (31)
CD4 T Cells Acting Independently of Antibody Contribute to Protective Immunity to Plasmodium chabaudi Infection After Apical Membrane Antigen 1 Immunization (2000) (30)
Conformational Dynamics and Antigenicity in the Disordered Malaria Antigen Merozoite Surface Protein 2 (2015) (30)
Candidate antigens for an asexual blood-stage vaccine. (1985) (30)
Structures of phage-display peptides that bind to the malarial surface protein, apical membrane antigen 1, and block erythrocyte invasion. (2003) (30)
Immunoprecipitation of biosynthetically‐labelled proteins from different Papua New Guinea Plasmodium falciparum isolates by sera from individuals in the endemic area (1981) (29)
Schistosoma japonicum: infection characteristics in mice of various strains and a difference in the response to eggs. (1981) (29)
Differential antibody screening of cloned Plasmodium falciparum sequences expressed in Escherichia coli: procedure for isolation of defined antigens and analysis of human antisera. (1984) (29)
Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains (2018) (28)
Structure of the FIRA gene of Plasmodium falciparum. (1987) (28)
Isolation of Peptides That Mimic Epitopes on a Malarial Antigen from Random Peptide Libraries Displayed on Phage (1999) (28)
Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype. (1997) (28)
Antigenic repeat structures in proteins of Plasmodium falciparum. (1986) (27)
Ligand-induced conformational change of Plasmodium falciparum AMA1 detected using 19F NMR. (2014) (27)
The major radioiodinated cuticular antigens of Onchocerca gibsoni microfilariae are neither species nor onchocerca specific. (1981) (27)
Two novel alleles within subfamilies of the merozoite surface antigen 2 (MSA-2) of Plasmodium falciparum. (1992) (27)
Isolation from Phage Display Libraries of Single Chain Variable Fragment Antibodies That Recognize Conformational Epitopes in the Malaria Vaccine Candidate, Apical Membrane Antigen-1* (1997) (26)
Field applications of agglutination and cytoadherence assays with Plasmodium falciparum from Papua New Guinea. (1989) (26)
Hybridoma antibody immunoassays for the detection of parasitic infection: development of a model system using a larval cestode infection in mice. (1979) (26)
An Experimental Model in Mink for Studying the Relation Between Amyloid Fibril Protein AA and the Related Serum Protein, SAA (1975) (25)
Association between cellular response (IL‐4) to RESA/Pf155 and protection from clinical malaria among Papua New Guinean children living in a malaria endemic area (1997) (25)
Sequence variation in S-antigen genes of Plasmodium falciparum. (1987) (25)
Coexistence of Protein AA and Immunoglobulin Light‐Chain Fragments in Amyloid Fibrils (1976) (25)
Refolding, purification, and crystallization of apical membrane antigen 1 from Plasmodium falciparum. (2005) (24)
Parasite Antigens and Their Immunogenicity in Infected Hosts (1982) (24)
Taenia taeniaeformis: immunoprecipitation analysis of the protein antigens of oncospheres and larvae. (1983) (24)
Structure and dynamics of apical membrane antigen 1 from Plasmodium falciparum FVO. (2014) (24)
New approaches to the serotypic analysis of the epidemiology of Plasmodium falciparum. (1988) (24)
The case for a subunit vaccine against malaria. (2011) (23)
Granulomatous hepatitis and cholangitis associated with giardiasis. (1982) (23)
Polymorphic antigens in Plasmodium falciparum. (1989) (23)
Immunization of mice against Taenia taeniaeformis using solubilized oncospheral antigens. (1982) (23)
Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status (1997) (23)
Identification of radioiodinated cuticular proteins and antigens of Onchocerca gibsoni microfilariae. (1981) (22)
Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii. (2001) (22)
Plasmodium falciparum: comparative analysis of erythrocyte stage-dependent protein antigens. (1982) (21)
High level sequence homology between a Plasmodium chabaudi heat shock protein gene and its Plasmodium falciparum equivalent. (1989) (21)
The S-antigen of Plasmodium falciparum: repertoire and origin of diversity. (1993) (21)
Lipid interactions of the malaria antigen merozoite surface protein 2. (2012) (21)
Mixed allele malaria vaccines: Host protection and within-host selection (2008) (20)
The malaria vaccine development program in Papua New Guinea. (2003) (20)
Patterns of antigen expression in asexual blood stages and gametocytes of Plasmodium falciparum. (1988) (20)
Invasion of erythrocytes in vitro by Plasmodium falciparum can be inhibited by monoclonal antibody directed against an S antigen (1985) (20)
Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate (2015) (19)
Molecular Insights into the Interaction between Plasmodium falciparum Apical Membrane Antigen 1 and an Invasion-Inhibitory Peptide (2014) (19)
Cloning and analysis of the RESA-2 gene: a DNA homologue of the ring-infected erythrocyte surface antigen gene of Plasmodium falciparum. (1992) (19)
Evidence that recurrent Plasmodium falciparum infection is caused by recrudescence of resistant parasites. (1997) (19)
Development of inhibitors of Plasmodium falciparum apical membrane antigen 1 based on fragment screening (2013) (19)
A Plasmodium chabaudi antigen located in the parasitophorous vacuole membrane. (1993) (18)
The alanine-rich heptad repeats are intact in the processed form of Plasmodium falciparum MSP3. (2004) (18)
Structure and function of candidate vaccine antigens in Plasmodium falciparum. (1987) (18)
The effect of fatty acids on the metabolism of lactic acid streptococci: I. Inhibition of bacterial growth and proteolysis (1964) (17)
The Impact of Immunization on Competition Within Plasmodium Infections (2008) (17)
Identification of key residues involved in fibril formation by the conserved N-terminal region of Plasmodium falciparum merozoite surface protein 2 (MSP2). (2010) (17)
Role of the helical structure of the N-terminal region of Plasmodium falciparum merozoite surface protein 2 in fibril formation and membrane interaction. (2012) (17)
Structure-Activity Studies of β-Hairpin Peptide Inhibitors of the Plasmodium falciparum AMA1-RON2 Interaction. (2016) (16)
Strain-transcending immune response generated by chimeras of the malaria vaccine candidate merozoite surface protein 2 (2016) (16)
Plasmodium falciparum complementary DNA clones expressed in Escherichia coli encode many distinct antigens. (1984) (16)
Peptide inhibitors of the malaria surface protein, apical membrane antigen 1: Identification of key binding residues (2011) (15)
An Experimental Model in Mink for Studying the Relation Between Amyloid Fibril Protein AA and the Related Serum Protein, SAA (1975) (15)
Variation in p126, a parasitophorous vacuole antigen of Plasmodium falciparum. (1988) (14)
Genetic studies in human and murine giardiasis. (1980) (14)
Plasmodium falciparum infection of splenectomized and intact Guyanan Saimiri monkeys. (1994) (14)
Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens (2015) (14)
Identification of a cDNA clone encoding a mature blood stage antigen of Plasmodium falciparum by immunization of mice with bacterial lysates. (1984) (14)
Hybridoma antibody immunoassays for the detection of parasitic infection: further studies on a monoclonal antibody with immunodiagnostic potential for Schistosomiasis japonica. (1981) (14)
A survey of the lactate dehydrogenase activities in group N streptococci. (1970) (13)
Development of a solid-phase radioimmunoassay for antibody to antigens of Babesia bovis infected bovine erythrocytes. (1982) (13)
Anti-idiotypic antibodies counteract the invasion inhibition capacity of antibodies to major epitopes of the Plasmodium falciparum antigen Pf155/RESA (1990) (12)
Genetic studies in human and murine giardiasis. (1993) (12)
The effect of fatty acids on the metabolism of pyruvate in lactic acid streptococci (1970) (11)
A Plasmodium falciparum gene encoding a high mobility group protein box. (1995) (11)
Vaccines Against Human Hookworm Disease (2004) (10)
Use of Immunodampening To Overcome Diversity in the Malarial Vaccine Candidate Apical Membrane Antigen 1 (2014) (10)
Specificities of antibodies boosted by acute Plasmodium falciparum infection in man. (1983) (10)
A High Molecular Weight Serum Protein Is the Carrier for Amyloid‐Related Protein SAA (1977) (9)
A critical evaluation of pyrrolo[2,3-d]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors (2014) (9)
cDNA sequence predicting an octapeptide-repeat antigen of Plasmodium falciparum. (1989) (8)
The nephrotic syndrome in Papua New Guinea: aetiological, pathological and immunological findings. (1977) (8)
Lymphocyte subpopulations and immune reactions in rheumatoid inflammatory tissues. (1975) (8)
Delayed-type hypersensitivity to liver F antigen in the mouse. (1980) (8)
The expression of Plasmodium falciparum bloodstage antigens in Escherichia coli. (1984) (8)
Identification in Human Placentae of Antigenic Activity Related to the Amyloid Serum Protein SAA (1977) (8)
Antigenic diversity in Plasmodium falciparum. (1991) (8)
Lipid interactions modulate the structural and antigenic properties of the C‐terminal domain of the malaria antigen merozoite surface protein 2 (2017) (7)
Infant Sleep Problems : Origins , Assessment (2005) (7)
A Phase 1 Trial of MSP 2-C 1 , a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP 2 Formulated with Montanide H ISA 720 (2011) (7)
Identification of antigenically active tryptic fragments of apical membrane antigen-1 (AMA1) of Plasmodium chabaudi malaria: strategies for assembly of immunologically active peptides. (2002) (6)
Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy. (1977) (6)
Amyloid fibril protein AA in Papua New Guinean amyloidosis. (1976) (6)
Repeat structures in malaria antigens. (1986) (5)
Examination of strategies for vaccination against parasitic infection or disease using mouse models. (1984) (5)
Letter to the Editor: Assignment of 1H, 13C and 15N resonances of domain III of the ectodomain of apical membrane antigen 1 from Plasmodium falciparum (2001) (5)
Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2. (2017) (5)
Cellular and Humoral Immunity in Giardiasis (1984) (5)
Secondary amyloidosis and the serum amyloid precursor in leprosy: geographical variation and association with leukocytosis. (1977) (4)
Antigens of the asexual stages of plasmodium falciparum (1986) (4)
Giardia and Giardiasis (1984) (4)
Antigens of Plasmodium falciparum and their potential as components of a malaria vaccine. (1988) (4)
Schistosoma japonicum: use of a radioimmunoassay for anti egg antibodies in human sera. (1981) (4)
The concentration of oleic acid in Cheddar cheese relative to loss of starter viability. (1970) (3)
Genetic studies inhumanandmurine giardiasis (1980) (3)
Plasmodium falciparum: a region of polymorphism in the 3' end of the gene for the ring-infected erythrocyte surface antigen. (1994) (3)
Cell-mediated immunologic status of healthy members of families with a history of leprosy. (1975) (3)
The effect of fatty acids on the metabolism of lactic acid streptococci: II. Resistance of a variant of Streptococcus cremoris strain C 13 (1964) (3)
Malaria vaccines. (2000) (2)
Modulation of the aggregation of an amyloidogenic sequence by flanking-disordered region in the intrinsically disordered antigen merozoite surface protein 2 (2018) (2)
Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum. (1985) (2)
The acquisition and maintenance of antibodies against Plasmodium falciparum merozoite antigens in childhood (2007) (2)
Induction of protective immunity to malaria. (1986) (2)
Plasmodium falciparum Asexual Blood Stage Vaccine Candidates: current Status (2004) (2)
Plasmodium Falciparum Merozoite Surface Protein 2 is Instrinsically Unstructured and Forms Amyloid-like Fibrils in vitro (2003) (1)
The resa protein of plasmodium falciparum is a phosphoprotein associated with the erythrocyte membrane skeleton (1989) (1)
CONNECTIVE TISSUE ORIGIN OF THE (1976) (1)
Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2. (2021) (1)
Measurement of antibody response to individual cloned antigens of Plasmodium falciparum. (1986) (1)
Guiding the Immune Response to a Conserved Epitope in MSP2, an Intrinsically Disordered Malaria Vaccine Candidate (2021) (1)
Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens (2015) (1)
Functional domain mapping of Plasmodium falciparum AMA-1 by phage display (2000) (0)
Antigens from Plasmodium falciparum. (1985) (0)
Hypersensitivity reactions as contributing factors to chronic in- fection with the intestinal protozoan parasite, giardia muris, in mice. (1983) (0)
Geographical distribution of amyloidosis in Papua New Guinea. (1976) (0)
A suite of kinetically superior AEP ligases can cyclise an intrinsically disordered protein (2019) (0)
The development of a malaria vaccine. (1991) (0)
The structured core of a largely unstructured protein, malarial merozoite surface protein 2 (MSP2), is amyloidogenic (2008) (0)
A Hot Spot for Binding of Invasion Inhibitory Molecules on the Malarial Protein Apical Membrane Antigen 1 (2003) (0)
The acquisition and maintenance of antibodies against P-falciparum merozoite antigens in childhood. (2008) (0)
Getting closer to a vaccine against malaria (2011) (0)
The effect of single amino acid substitutions on antigenicity of vaccine candidate proteins using phage display. (2003) (0)
Thecomplete sequenceofthegene fortheknob-associated histidine-rich protein fromPlasmodium falciparum (1987) (0)
Towards Peptide Antibody Strategies for the Control of Malaria Invasion (2003) (0)
Antibodies to peptide mimics block malaria invasion of red blood cells. (2003) (0)
Interspersed blocks ofrepetitive andcharged aminoacids ina dominant immunogen ofPlasmodium falciparum (1985) (0)
Antigenic characterization of polymorphic forms of Plasmodium falciparum AMA1. (2002) (0)
FVO Plasmodium falciparum AMA1 (2018) (0)
Workshop 1P: Malaria immunology (1987) (0)
Specificity variants in monoclonal antibodies reactive with peptide epitopes of the ring‐infected erythrocyte surface antigen (RESA) of Plasmodium falciparum (1993) (0)
Symposium stream 1: Molecular biology and genetics of parasites (1987) (0)
Abundance of Intrinsically Unstructured Proteins ( IUPs ) in P . 4 falciparum and other Apicomplexan Parasite Proteomes (2009) (0)
LONGITUDINAL PATTERNS OF ANTIBODY RESPONSES AND PLASMODIUM SPP. INFECTION DURING PREGNANCY (2010) (0)
PHAGE DISPLAY PEPTIDES BIND TO THE MALARIAL PROTEIN APICAL MEMBRANE ANTIGEN-1 AND INHIBIT THE INVASION OF MEROZOITES INTO HOST ERYTHROCYTES (2002) (0)
AMA1 from Plasmodium falciparum (2005) (0)
Vaccinating Against Malaria with Recombinant Proteins: How Critical is Protein Conformation? (2003) (0)
REFOLDING, PURIFICATINO, AND CRYSTALLIZATION OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM (2005) (0)
Modulation of the aggregation of an amyloidogenic sequence by flanking-disordered region in the intrinsically disordered antigen merozoite surface protein 2 (2018) (0)
Nucleic Acids Research (2016) (0)
Protein 2 Plasmodium falciparum Merozoite Surface Intrinsically Unstructured Protein, Antigenic Characterization of an (2012) (0)
CRC-Vaccine Technology (2008) (0)
The acquisition of invasion inhibitory antibodies and antibodies to erythrocyte invasion ligands of Plasmodium falciparum (2007) (0)
Investigating the Immunoreactive Regions of Apical Membrane Antigen 1, a Vaccine Candidate (2003) (0)
Integrated Phage Display Approach to the Study and Design of Proteins. (2003) (0)
Development of a 2-site ELISA to Quantify AMA1 Expression Levels. (2002) (0)
Structure of IgNAR single domain antibody and Plasmodium falciparum AMA1 complex (2007) (0)
Isolation and Characterisation of Peptides that Bind to Apical Membrane Antigen 1 of the Malaria Causing Parasite Plasmodium Falciparum. (2003) (0)
Antigene aus plasmodium-falciparum. (1985) (0)
Antibody acquisition against apical membrane antigen 1 in a cohort of children and the relationship to malaria exposure and protective immunity [MIM-CM-40691] (2005) (0)
Invasion by Plasmodium falciparum Proteins during and after Erythrocyte Sequential Processing of Merozoite Surface (2014) (0)
Correction: Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1 (2014) (0)
MEROZOITE SURFACE PROTEIN 2 HAS A POTENTIAL ROLE IN THE ATTACHMENT OF PLASMODIUM FALCIPARUM MEROZOITES TO ERYTHROCYTES DURING INVASION (2009) (0)
Antigenes hautement repetitifs de plasmodium falciparum. (1986) (0)
The use of random peptide libraries as a tool for studying the malarial protein paical membrane antigen-1 (2000) (0)
The Effect of Individual Disulfide Bond Elimination on Antigenicity of Vaccine Candidate Proteins Using Phage Display. (2003) (0)
Progress Towards a Recombinant Protein Malaria Vaccine (2003) (0)
Antibody Recognition of D isordered Antigens Graphical (2015) (0)
Crystal Structure of anti-MSP2 Fv fragment (mAb4D11) in complex with 3D7-MSP2 215-222 (2015) (0)
Development of Plasmodium falciparum merozoite surface protein 2 as a vaccine candidate (2003) (0)
Order, Disorder and Fibril Formation in the Malaria Vaccine Candidate MSP2 (2008) (0)
Optimisation of Fermentation Conditions for Production of Recombinant Plasmodium Falciparum (3D7) AMA1 for Clinical Trials. (2002) (0)
Clonal repertoire analysis of murine B cells specific for repeat sequence antigens of Plasmodium falciparum (1990) (0)
Acknowledgment of Ad Hoc Reviewers (2013) (0)
Fc and Fc-like receptors (PP-095) (2010) (0)
Structural Studies of Domains I and II of a Malarial Vaccine Candidate, AMA1, from the Parasite Plasmodium Falciparum (2003) (0)
Peptides that mimic epitopes on malarial antigens isolated form random peptide libraries displayed on phage (2000) (0)
Amyloid fibril proteins found in Papua New Guinean and other amyloidoses. (1978) (0)
The acquisition of invasion inhibitory antibodies and antibodies to erythrocyte invasion ligands of P-falciparum. (2008) (0)
Malaria Vaccine Development (2003) (0)

This paper list is powered by the following services:

Other Resources About Robin Fredric Anders

scholars.latrobe.edu.au

What Schools Are Affiliated With Robin Fredric Anders?

Robin Fredric Anders is affiliated with the following schools: